Endogenous anti‐tumor antibody responses in nude mice

BACKGROUND Nude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization and radioimmunotherapy. These animals accept transplants and are generally considered immunologically inert with regard to cell‐mediated and hu...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 80; no. S12; pp. 2404 - 2410
Main Authors Stigbrand, Torgny, Ullén, Anders, Sandström, Per, Rathsman, Sandra, Norrlund, Rauni Rossi, Ärlestig, Lisbeth, Åhlström, Katrine Riklund, Hietala, Sven‐Ola
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York John Wiley & Sons, Inc 15.12.1997
Wiley-Liss
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND Nude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization and radioimmunotherapy. These animals accept transplants and are generally considered immunologically inert with regard to cell‐mediated and humoral immune responses against the tumors. METHODS Nude control mice and mice carrying human HeLa Hep‐2 tumor xenografts were studied for appearance of endogenous antibodies following inoculation with tumor cells. The titers of these antibodies were investigated by isotype‐specific enzyme‐linked immunosorbent assay (ELISA) technologies, fluorescence‐activated cell sorter analysis (FACS), BIAcore (Pharmacia Biosensor AB, Uppsala, Sweden) technology, and immunofluorescence. RESULTS The HeLa Hep‐2 cell line was found to be immunogenic in all investigated animals by means of ELISA, FACS, and BIAcore evaluations as well as by immunofluorescence against both tested antigens, placental alkaline phosphatase and cytokeratin 8. Predominantly immunoglobulin M antibodies were induced, but immunoglobulin G isotypes could also be identified. Sera from these tumor‐bearing mice were used for immunohistochemistry of the tumor cells. The antibodies seemed to be of low affinity and may be displaced by high‐affinity monoclonal antibodies used in radioimmunotargeting. CONCLUSIONS Nude mice bearing tumor xenografts produce significant amounts of antibodies against these two human tumor‐derived antigens. These endogenous antibodies may influence targeting of radiolabeled antibodies. They also have the potential to interfere with the pharmacokinetics of labeled or nonlabeled idiotypic antibodies during experimental immunolocalization. Cancer 1997; 80:2404‐10. © 1997 American Cancer Society. Nude mice bearing tumor xenografts produce significant amounts of immunoglobulin G and M antibodies against two tumor cell‐derived human antigens, cytokeratin 8 and human placental alkaline phosphatase.
AbstractList BACKGROUNDNude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization and radioimmunotherapy. These animals accept transplants and are generally considered immunologically inert with regard to cell-mediated and humoral immune responses against the tumors.METHODSNude control mice and mice carrying human HeLa Hep-2 tumor xenografts were studied for appearance of endogenous antibodies following inoculation with tumor cells. The titers of these antibodies were investigated by isotype-specific enzyme-linked immunosorbent assay (ELISA) technologies, fluorescence-activated cell sorter analysis (FACS), BIAcore (Pharmacia Biosensor AB, Uppsala, Sweden) technology, and immunofluorescence.RESULTSThe HeLa Hep-2 cell line was found to be immunogenic in all investigated animals by means of ELISA, FACS, and BIAcore evaluations as well as by immunofluorescence against both tested antigens, placental alkaline phosphatase and cytokeratin 8. Predominantly immunoglobulin M antibodies were induced, but immunoglobulin G isotypes could also be identified. Sera from these tumor-bearing mice were used for immunohistochemistry of the tumor cells. The antibodies seemed to be of low affinity and may be displaced by high-affinity monoclonal antibodies used in radioimmunotargeting.CONCLUSIONSNude mice bearing tumor xenografts produce significant amounts of antibodies against these two human tumor-derived antigens. These endogenous antibodies may influence targeting of radiolabeled antibodies. They also have the potential to interfere with the pharmacokinetics of labeled or nonlabeled idiotypic antibodies during experimental immunolocalization.
BACKGROUND Nude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization and radioimmunotherapy. These animals accept transplants and are generally considered immunologically inert with regard to cell‐mediated and humoral immune responses against the tumors. METHODS Nude control mice and mice carrying human HeLa Hep‐2 tumor xenografts were studied for appearance of endogenous antibodies following inoculation with tumor cells. The titers of these antibodies were investigated by isotype‐specific enzyme‐linked immunosorbent assay (ELISA) technologies, fluorescence‐activated cell sorter analysis (FACS), BIAcore (Pharmacia Biosensor AB, Uppsala, Sweden) technology, and immunofluorescence. RESULTS The HeLa Hep‐2 cell line was found to be immunogenic in all investigated animals by means of ELISA, FACS, and BIAcore evaluations as well as by immunofluorescence against both tested antigens, placental alkaline phosphatase and cytokeratin 8. Predominantly immunoglobulin M antibodies were induced, but immunoglobulin G isotypes could also be identified. Sera from these tumor‐bearing mice were used for immunohistochemistry of the tumor cells. The antibodies seemed to be of low affinity and may be displaced by high‐affinity monoclonal antibodies used in radioimmunotargeting. CONCLUSIONS Nude mice bearing tumor xenografts produce significant amounts of antibodies against these two human tumor‐derived antigens. These endogenous antibodies may influence targeting of radiolabeled antibodies. They also have the potential to interfere with the pharmacokinetics of labeled or nonlabeled idiotypic antibodies during experimental immunolocalization. Cancer 1997; 80:2404‐10. © 1997 American Cancer Society. Nude mice bearing tumor xenografts produce significant amounts of immunoglobulin G and M antibodies against two tumor cell‐derived human antigens, cytokeratin 8 and human placental alkaline phosphatase.
Nude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization and radioimmunotherapy. These animals accept transplants and are generally considered immunologically inert with regard to cell-mediated and humoral immune responses against the tumors. Nude control mice and mice carrying human HeLa Hep-2 tumor xenografts were studied for appearance of endogenous antibodies following inoculation with tumor cells. The titers of these antibodies were investigated by isotype-specific enzyme-linked immunosorbent assay (ELISA) technologies, fluorescence-activated cell sorter analysis (FACS), BIAcore (Pharmacia Biosensor AB, Uppsala, Sweden) technology, and immunofluorescence. The HeLa Hep-2 cell line was found to be immunogenic in all investigated animals by means of ELISA, FACS, and BIAcore evaluations as well as by immunofluorescence against both tested antigens, placental alkaline phosphatase and cytokeratin 8. Predominantly immunoglobulin M antibodies were induced, but immunoglobulin G isotypes could also be identified. Sera from these tumor-bearing mice were used for immunohistochemistry of the tumor cells. The antibodies seemed to be of low affinity and may be displaced by high-affinity monoclonal antibodies used in radioimmunotargeting. Nude mice bearing tumor xenografts produce significant amounts of antibodies against these two human tumor-derived antigens. These endogenous antibodies may influence targeting of radiolabeled antibodies. They also have the potential to interfere with the pharmacokinetics of labeled or nonlabeled idiotypic antibodies during experimental immunolocalization.
Author Sandström, Per
Rathsman, Sandra
Stigbrand, Torgny
Ärlestig, Lisbeth
Hietala, Sven‐Ola
Norrlund, Rauni Rossi
Ullén, Anders
Åhlström, Katrine Riklund
Author_xml – sequence: 1
  givenname: Torgny
  surname: Stigbrand
  fullname: Stigbrand, Torgny
– sequence: 2
  givenname: Anders
  surname: Ullén
  fullname: Ullén, Anders
– sequence: 3
  givenname: Per
  surname: Sandström
  fullname: Sandström, Per
– sequence: 4
  givenname: Sandra
  surname: Rathsman
  fullname: Rathsman, Sandra
– sequence: 5
  givenname: Rauni Rossi
  surname: Norrlund
  fullname: Norrlund, Rauni Rossi
– sequence: 6
  givenname: Lisbeth
  surname: Ärlestig
  fullname: Ärlestig, Lisbeth
– sequence: 7
  givenname: Katrine Riklund
  surname: Åhlström
  fullname: Åhlström, Katrine Riklund
– sequence: 8
  givenname: Sven‐Ola
  surname: Hietala
  fullname: Hietala, Sven‐Ola
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2131038$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9406690$$D View this record in MEDLINE/PubMed
BookMark eNp9kN1q2zAUx8Xo6NJsjzDwxRgtxdk5kuKPrBSK16aBssA-YLDBQZbl4WHLmRVTcrdH2DPuSSY3Xm42diWOzl9Hv_M7YUe2tYaxDGGGAPzV6ftVtjpDSOMQUPJTTNMYOc7PElggP7_gEuRicbV6E2Zvs3eIl2IGs2z9mofLR2xyeHfEJgCQhHMpPj1hJ85982XM5-KYHacSoiiFCYuvbdF-NbbtXaDstvr14-e2b9ruocjbYhd0xm1a64wLKhvYvjBBU2nzlD0uVe3Ms_Gcso831x-y2_BuvVxlV3eh9pAY5irNRSLiCEv_YaELxUsuU25KvxKqREWyMNJwqXmBquSliFBqE-V5IgVoJabs5X7upmu_98ZtqamcNnWtrPHMFKcy9htHPvh5H9Rd61xnStp0VaO6HSHQoJVo0EqDHhr00B-tlPiAbw9aibxW2mslQUDZmjgt_fTnI0afN6Y4zB49-v6Lsa-cVnXZKasrd4hxFAjew5R92cfuq9rs_iL8P-AD3z_xxhvxG_hDo18
CODEN CANCAR
Cites_doi 10.1111/j.1432-1033.1983.tb07697.x
10.1002/nbm.1940050507
10.1159/000217650
10.1016/0008-8749(91)90326-7
10.3109/02841869309096141
10.1177/37.12.2479674
ContentType Journal Article
Conference Proceeding
Copyright Copyright © 1997 American Cancer Society
1998 INIST-CNRS
Copyright_xml – notice: Copyright © 1997 American Cancer Society
– notice: 1998 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0142
EndPage 2410
ExternalDocumentID 10_1002__SICI_1097_0142_19971215_80_12__2404__AID_CNCR11_3_0_CO_2_G
9406690
2131038
CNCR11
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Lions Foundation
– fundername: Swedish Cancer Research Council
  funderid: 4187
– fundername: Medical Faculty at University of Umeå
– fundername: Garden State Cancer Center ; Center for Molecular Medicine and Immunology
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1L6
1OC
24P
29B
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AARRQ
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHFT
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AGNAY
AHBTC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
F00
F01
F04
F5P
FD6
FUBAC
G-S
G.N
GNP
GODZA
GX1
H.X
HBH
HGLYW
HHY
HHZ
HZ~
H~9
IH2
IX1
J0M
J5H
JPC
KBYEO
KQQ
KZ1
L7B
LATKE
LAW
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
SJN
SUPJJ
TEORI
UDS
UHB
V2E
V8K
V9Y
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XPP
XV2
Y6R
Z0Y
ZGI
ZXP
ZZTAW
~IA
~WT
08R
AAJUZ
AAUGY
AAVGM
ABCVL
ABHUG
ABPTK
ABWRO
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
AKALU
C1A
EMOBN
EX3
HF~
IQODW
LMP
RSU
RYL
WHG
XFK
YQJ
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4041-ba9b383761f066dcda2f2492ef9711a8a64de4e24c2d1af2f3614ce6bb8430ca3
IEDL.DBID DR2
ISSN 0008-543X
IngestDate Fri Aug 16 09:03:34 EDT 2024
Fri Aug 23 00:46:43 EDT 2024
Sat Sep 28 08:40:41 EDT 2024
Sun Oct 22 16:08:06 EDT 2023
Sat Aug 24 01:04:28 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue S12
Language English
License CC BY 4.0
LinkModel DirectLink
MeetingName Conference on Radioimmunodetection and Radioimmunotherapy of Cancer
MergedId FETCHMERGED-LOGICAL-c4041-ba9b383761f066dcda2f2492ef9711a8a64de4e24c2d1af2f3614ce6bb8430ca3
Notes Presented at the Sixth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer, Princeton, New Jersey, October 10‐12, 1996.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 9406690
PQID 79471096
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_79471096
crossref_primary_10_1002__SICI_1097_0142_19971215_80_12__2404__AID_CNCR11_3_0_CO_2_G
pubmed_primary_9406690
pascalfrancis_primary_2131038
wiley_primary_10_1002_SICI_1097_0142_19971215_80_12_2404_AID_CNCR11_3_0_CO_2_G_CNCR11
PublicationCentury 1900
PublicationDate 15 December 1997
PublicationDateYYYYMMDD 1997-12-15
PublicationDate_xml – month: 12
  year: 1997
  text: 15 December 1997
  day: 15
PublicationDecade 1990
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: New York, NY
– name: United States
PublicationTitle Cancer
PublicationTitleAlternate Cancer
PublicationYear 1997
Publisher John Wiley & Sons, Inc
Wiley-Liss
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley-Liss
References 1995
1983; 136
1990; 11
1991; 134
1989; 37
1995; 1
1993; 32
1995; 55
1992; 5
Ullén (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB9) 1995; 55
Buchsbaum (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB3) 1995
Denekamp (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB1) 1992; 5
Sundström (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB7) 1990; 11
Hillman (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB4) 1991; 134
Sundström (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB6) 1989; 37
Riklund Åhlström (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB8) 1995; 1
Aas (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB2) 1993; 32
Millan (10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB5) 1983; 136
References_xml – volume: 37
  start-page: 1845
  year: 1989
  end-page: 54
  article-title: Diversity in immunoreactivity of tumor derived cytokeratin monoclonal antibodies
  publication-title: J Histochem Cytochem
– volume: 11
  start-page: 158
  year: 1990
  end-page: 66
  article-title: Radioimmunolocalization in nude mice using anticytokeratin monoclonal antibodies
  publication-title: Tumor Biol
– volume: 134
  start-page: 1
  year: 1991
  end-page: 13
  article-title: A polymer containing a repeating peptide sequence can stimulate T‐cell‐independent IgG antibody production in vivo
  publication-title: Cell Immunol
– volume: 5
  start-page: 234
  year: 1992
  end-page: 7
  article-title: The choice of experimental models in cancer research: the key to ultimate success or failure?
  publication-title: NMR Biomed
– start-page: 21
  year: 1995
  end-page: 31
– volume: 136
  start-page: 1
  year: 1983
  end-page: 7
  article-title: Antigenic determinants of human placental and testicular alkaline phosphatase as mapped by monoclonal antibodies
  publication-title: Eur J Biochem
– volume: 1
  start-page: 239
  year: 1995
  end-page: 44
  article-title: Radioimmunotherapy of HeLa cell tumors in nude mice by a combination of iodidine‐131‐labeled monoclonal antibodies against placental alkaline phosphatase and cytokeratin
  publication-title: Tumor Targeting
– volume: 55
  start-page: 5868
  year: 1995
  end-page: 73
  article-title: Use of anticytokeratin monoclonal anti‐idiotypic antibodies to improve tumor: nontumor ratio in experimental radioimmunolocalization
  publication-title: Cancer Res
– volume: 32
  start-page: 819
  year: 1993
  end-page: 24
  article-title: Animal models for radiolabeled monoclonal antibodies in cancer research
  publication-title: Acta Oncol
– volume: 136
  start-page: 1
  year: 1983
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB5
  publication-title: Eur J Biochem
  doi: 10.1111/j.1432-1033.1983.tb07697.x
  contributor:
    fullname: Millan
– volume: 1
  start-page: 239
  year: 1995
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB8
  publication-title: Tumor Targeting
  contributor:
    fullname: Riklund Åhlström
– volume: 5
  start-page: 234
  year: 1992
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB1
  publication-title: NMR Biomed
  doi: 10.1002/nbm.1940050507
  contributor:
    fullname: Denekamp
– volume: 11
  start-page: 158
  year: 1990
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB7
  publication-title: Tumor Biol
  doi: 10.1159/000217650
  contributor:
    fullname: Sundström
– volume: 134
  start-page: 1
  year: 1991
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB4
  publication-title: Cell Immunol
  doi: 10.1016/0008-8749(91)90326-7
  contributor:
    fullname: Hillman
– volume: 32
  start-page: 819
  year: 1993
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB2
  publication-title: Acta Oncol
  doi: 10.3109/02841869309096141
  contributor:
    fullname: Aas
– start-page: 21
  volume-title: Cancer therapy with radiolabeled antibodies
  year: 1995
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB3
  contributor:
    fullname: Buchsbaum
– volume: 37
  start-page: 1845
  year: 1989
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB6
  publication-title: J Histochem Cytochem
  doi: 10.1177/37.12.2479674
  contributor:
    fullname: Sundström
– volume: 55
  start-page: 5868
  year: 1995
  ident: 10.1002/(SICI)1097-0142(19971215)80:12+<2404::AID-CNCR11>3.0.CO;2-G-BIB9
  publication-title: Cancer Res
  contributor:
    fullname: Ullén
SSID ssj0007253
Score 1.5920582
Snippet BACKGROUND Nude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization...
Nude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization and...
BACKGROUNDNude mice with xenografted human tumors is the most exploited animal model used to elucidate the efficacy of experimental radioimmunolocalization and...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 2404
SubjectTerms Alkaline Phosphatase - immunology
Animals
Antibodies, Neoplasm - biosynthesis
BIAcove
Biological and medical sciences
cytokeratin
Enzyme-Linked Immunosorbent Assay
Female
Fluorescent Antibody Technique
Humans
immunoglobulin
Keratins - immunology
Medical sciences
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Transplantation
Neoplasms, Experimental - immunology
nude mice
placental alkaline phosphatase
Radiation therapy and radiosensitizing agent
radioimmunolocalization
radioimmunotherapy
Transplantation, Heterologous
Treatment with physical agents
Treatment. General aspects
Tumors
Title Endogenous anti‐tumor antibody responses in nude mice
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%2B%3C2404%3A%3AAID-CNCR11%3E3.0.CO%3B2-G
https://www.ncbi.nlm.nih.gov/pubmed/9406690
https://search.proquest.com/docview/79471096
Volume 80
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwxV3datswFBalF2Uw9l-Wbt18sULLcCpLiiJnY9B6aZtBW-gayJ3QL5RRp-TnYrsa7AX2EHuyPcmOLDshW9ndGOTGjuNz8uno6JN1_AmhV11jLBfYpoZplzKB81T4UCaGnRXMC96ptuk8PeMnQ_Zh1BmtoW_NuzBRH2LxwC30jCpfhw6u9HR_KRoKBOzjoBjAhDksosKUmJEgbZTn3SiYkAsc5Ajg5OEOLWDgYnAIn4PB-7Q4Ky4gU9A-beN2cb5DD0l6DHk8CPIFYnWxlKDqklrJEou0w-hoAxW1D_u7wf7ewvpuY3tP4F5GXr8NNnu9pb130dobsLUyCt69UVNoEB930riN6q4y52roO7qPfjSgxYqXT-35TLfNl9_0JP8zqg_QvZpaJwexLzxEa658hDZO6-KBx6jbL-04atImEE9XP79-n82vx5PqQI_t52QSC4bdNLkqk3JuXXINefQJGh71L4uTtN43AgIOsyzVKtdh4s0zD4TKGquID8KIzsO_yJRQnFnHHGGG2Ex54ilwFOO41oJRbBTdROvluHRPUaK59YwqI5jJmVNCM4cp1d5w3vW5Ji102bSjvInyIDIKQRMpA5D1Cj_AKBsQpYAL4OsAnpQAnIzASSqxLM4lkccttL0SE4t7kyzsCyda6GUTIxLSQVjjUaUD-CSk11Bdy1toM4bO4qc5UDee4xYaVu3_h7t_97Zy9lZf6zNb_-i-z9CdSjE4I2nWeY7WZ5O52wYeONMvqo76CwjXN4E
link.rule.ids 310,311,315,786,790,795,796,1382,23958,23959,25170,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwxV3dbtMwFLbGkAYS4n-iwFgumLQJpXNsx3UKQtpCtxbWThqt1DsrdmxpQkunrr2AKy54AF6CF-NJOI6TVoWJO4SUG-fvnHw-Pj62Tz4j9LKldc4FzkPNlAmZwEkorEsTwyYXzAoel9t09ge8O2Lvx_F4DX2r_4Xx_BCLCTfXMkp_7Rq4m5DeX7KGQgT2sZf2YMTsVlFhTMyI4zZKkpZnTEgEdnwEcPJwh6bQczEownHQexemg_QMXAXt0CZupqc79JCExzfQTXAbcTkwO1uSULVIxWWJRRgzOt5AaaXE_q5TYG8hfrcWvidwOyKv3jih7fZS4Fsv7jUIW-kH71xmV1Al1u-lcV2wuxo7l53f0T30o4bN57x8as5nqqm__MYo-b9xvY_uVtF1cOCbwwO0ZoqHaKNf5Q88Qq1OkU88LW0AJnX-8-v32fxiMi0LapJ_DqY-Z9hcBedFUMxzE1yAK32MRkedYdoNq60jwOYwi0KVJcqNvXlkIabKdZ4R67gRjYWviDKRcZYbZgjTJI8ySyyFMEUbrpRgFOuMbqL1YlKYJyhQPLeMZlownTCTCcUMplRZzXnLJoo00LCuSHnpGUKk54ImUjogq0V-gFHWIEoBN8BlB56UAJz0wEkqsUxPJZHHDbS1YhSLd5PIbQ0nGmi7NhIJHsEt82SFAfgkeFiXYMsbaNPbzuLRBKI3nuAGGpUG8Ie6f9e2VPZaXaszT__Re7fRre6wfyJPeoMPz9DtkkA4ImEUP0frs-ncbEFYOFMvylb7C8nPO6M
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwxV3dbtMwFLbGkCokNH4nOhjLBZM2oXSO7bpOQUhb2m4F1qGxSr2z4tiWJrS06toLuELiBXgInown4ThOWhUm7hBSbvJ7Tj6fc3wcn3xG6EUryzQXWIcZUyZkAsehsK5MDBstmBW8WSzTeTrgJ0P2dtQcraFv1b8wnh9i8cHNeUYRr52DT7Q9WJKGQgL2sZ_0YcDsJlFhSMyIozaK45YnTIgFdnQEcPBolybQcTHYhe2w3wmTQXIOkYJ2aQM3krNdekTC41voNuOUONfonC85qFqkpLLEImwyOqqhpFTiYM8psL8Qv1cJ3xe4HZGXr53Qdnsp8I0X9wqErXSDdyfpNbSI9Utp3JTrrqbORd_Xu4d-VKj5kpdPjflMNbIvvxFK_mdY76ONMrcODr0zPEBrJn-Iaqdl9cAj1OrmeuxJaQMwqMufX7_P5lfjabGjxvpzMPUVw-Y6uMyDfK5NcAWB9DEa9roXyUlYLhwBFodZFKo0Vm7kzSMLGZXOdEqsY0Y0Ft4iSkXKmTbMEJYRHaWWWApJSma4UoJRnKV0E63n49w8QYHi2jKaZoJlMTOpUMxgSpXNOG_ZWJE6uqjaUU48P4j0TNBESgdkOcUPMMoKRCngAjjtwJMSgJMeOEkllsmZJPK4jrZXbGLxbBK5heFEHe1UNiIhHrhJnjQ3AJ-E-OrKa3kdbXrTWdwaQ-7GY1xHw6L9_1D379oWyt6oa3lk6x89dwfVPnR68n1_8O4pulOwB0ckjJrP0PpsOjfbkBPO1PPCZ38Bq8s6Ug
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Cancer&rft.atitle=Endogenous+anti-tumor+antibody+responses+in+nude+mice&rft.au=STIGBRAND%2C+T&rft.au=ULLEN%2C+A&rft.au=SANDSTR%C3%96M%2C+P&rft.au=RATHSMAN%2C+S&rft.date=1997-12-15&rft.pub=Wiley-Liss&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=80&rft.issue=12&rft.spage=2404&rft.epage=2410&rft_id=info:doi/10.1002%2F%28SICI%291097-0142%2819971215%2980%3A12%2B%3C2404%3A%3AAID-CNCR11%3E3.0.CO%3B2-G&rft.externalDBID=n%2Fa&rft.externalDocID=2131038
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon